{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:56:24Z","timestamp":1791903384202,"version":"4.3.4"},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,4,25]]},"DOI":"10.1253\/circj.cj-24-0813","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:15:29Z","timestamp":1740694529000},"page":"566-573","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Comparison of High- and Low-Dose Drug-Coated Balloons for De Novo Chronic Total Occlusive Femoropopliteal Lesions"],"prefix":"10.1253","volume":"89","author":[{"given":"Kenji","family":"Ogata","sequence":"first","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"},{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Nishihira","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Komiya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensho","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kadooka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ashikaga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, et al. SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. <i>Catheter Cardiovasc Interv<\/i> 2018; 92: 124\u2013140.","DOI":"10.1002\/ccd.27635"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by The European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). <i>Eur Heart J<\/i> 2018; 39: 763\u2013816.","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. <i>J Am Coll Cardiol<\/i> 2012; 59: 16\u201323.","DOI":"10.1016\/j.jacc.2011.09.036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nagita H, Wang C, Saigusa H, Hoshina K, Suhara M, Oshima M. Deformed popliteal artery due to highly flexed knee position can cause kinks, creating an unfavorable hemodynamic state. <i>Circ J<\/i> 2024; 88: 351\u2013358.","DOI":"10.1253\/circj.CJ-23-0672"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ogata K, Nishihira K, Asano Y, Honda Y, Yamamoto K, Emori H, et al. Clinical comparison of drug-coated balloon and drug-eluting stent for femoropopliteal lesions in chronic limb-threatening ischemia with wounds. <i>Circ J<\/i> 2024; 88: 1647\u20131655.","DOI":"10.1253\/circj.CJ-24-0176"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. <i>N Engl J Med<\/i> 2015; 373: 145\u2013153.","DOI":"10.1056\/NEJMoa1406235"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. <i>Circulation<\/i> 2015; 131: 495\u2013502.","DOI":"10.1161\/CIRCULATIONAHA.114.011004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, et al. 12-month results from the first-in-human randomized study of the Ranger paclitaxel-coated balloon for femoropopliteal treatment. <i>JACC Cardiovasc Interv<\/i> 2018; 11: 934\u2013941.","DOI":"10.1016\/j.jcin.2018.01.276"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, et al. COMPARE: Prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. <i>Eur Heart J<\/i> 2020; 41: 2541\u20132552.","DOI":"10.1093\/eurheartj\/ehaa049"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mori S, Yamauchi Y, Doijiri T, Tobita K, Hishikari K, Honda Y, et al. Comparison between clinical outcomes of low- and high-dose paclitaxel drug-coated balloon in endovascular therapy for femoropopliteal lesion. <i>Cardiovasc Intervent Radiol<\/i> 2023; 46: 590\u2013597.","DOI":"10.1007\/s00270-022-03289-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N, et al. Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease: The PROSPECT MONSTER study outcomes. <i>JACC Cardiovasc Interv<\/i> 2023; 16: 2655\u20132665.","DOI":"10.1016\/j.jcin.2023.08.022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fujihara M, Takahara M, Soga Y, Iida O, Kawasaki D, Tomoi Y, et al. Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: A sub-analysis of the POPCORN registry. <i>CVIR Endovasc<\/i> 2023; 6: 41.","DOI":"10.1186\/s42155-023-00390-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: Assessment using the peripheral artery calcification scoring system. <i>J Endovasc Ther<\/i> 2016; 23: 731\u2013737.","DOI":"10.1177\/1526602816656612"},{"key":"14","unstructured":"14. Rogers JH, Lasala JM. Coronary artery dissection and perforation complicating percutaneous coronary intervention. <i>J Invasive Cardiol<\/i> 2004; 16: 493\u2013499."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tomoi Y, Soga Y, Imada K, Sakai N, Katsuki T, Ando K. Impact of a less than 50% residual stenosis following vessel preparation in femoropopliteal drug-coated balloon angioplasty. <i>J Endovasc Ther<\/i> 2024; 9: 15266028231223086.","DOI":"10.1177\/15266028231223086"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tepe G, Micari A, Keirse K, Zeller T, Scheinert D, Li P, et al. Drug-coated balloon treatment for femoropopliteal artery disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study. <i>JACC Cardiovasc Interv<\/i> 2019; 12: 484\u2013493.","DOI":"10.1016\/j.jcin.2018.12.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. <i>J Am Heart Assoc<\/i> 2023; 12: e025677.","DOI":"10.1161\/JAHA.122.025677"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, et al. Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. <i>J Endovasc Ther<\/i> 2017; 24: 367\u2013375.","DOI":"10.1177\/1526602817698634"},{"key":"19","unstructured":"19. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. <i>J Vasc Surg<\/i> 2019; 69: 3S\u2013125S.e40."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tsujimura T, Iida O, Ishihara T, Asai M, Masuda M, Okamoto S, et al. Angioscopic evaluation of vascular response after fluoropolymer-based drug-eluting stent implantation for femoropopliteal artery lesions. <i>Circ J<\/i> 2023; 87: 432\u2013429.","DOI":"10.1253\/circj.CJ-22-0635"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tan M, Urasawa K, Koshida R, Haraguchi T, Kitani S, Igarashi Y, et al. Comparison of angiographic dissection patterns caused by long vs short balloons during balloon angioplasty of chronic femoropopliteal occlusions. <i>J Endovasc Ther<\/i> 2018; 25: 192\u2013200.","DOI":"10.1177\/1526602818756610"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Horie K, Tanaka A, Taguri M, Inoue N. Impact of scoring balloons on percutaneous transluminal angioplasty outcomes in femoropopliteal lesions. <i>J Endovasc Ther<\/i> 2020; 27: 481\u2013491.","DOI":"10.1177\/1526602820914618"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shirai S, Mori S, Yamaguchi K, Mizusawa M, Chishiki T, Makino K, et al. Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion. <i>CVIR Endovasc<\/i> 2022; 5: 46.","DOI":"10.1186\/s42155-022-00324-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Allan RB, Puckridge PJ, Spark JI, Delaney CL. The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions: A randomized controlled trial. <i>JACC Cardiovasc Interv<\/i> 2022; 15: 536\u2013546.","DOI":"10.1016\/j.jcin.2022.01.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kurata N, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, et al. Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. <i>J Endovasc Ther<\/i> 2023; 30: 269\u2013280.","DOI":"10.1177\/15266028221081082"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kurata N, Iida O, Asai M, Okamoto S, Ishihara T, Nanto K, et al. Factors in sufficient endovascular vessel preparation for severely calcified femoropopliteal lesions. <i>Circ J<\/i> 2023; 87: 424\u2013431.","DOI":"10.1253\/circj.CJ-22-0444"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hayakawa N, Takahara M, Nakama T, Horie K, Takanashi K, Kanagami T, et al. Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: Results from the multicenter EAGLE study. <i>CVIR Endovasc<\/i> 2022; 5: 51.","DOI":"10.1186\/s42155-022-00329-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Toyoshima T, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Intraluminal vs subintimal drug-coated balloon angioplasty for the treatment of femoropopliteal chronic total occlusions. <i>JACC Cardiovasc Interv<\/i> 2024; 17: 608\u2013618.","DOI":"10.1016\/j.jcin.2023.12.028"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Horie K, Takahara M, Nakama T, Tanaka A, Tobita K, Hayakawa N, et al. Impact of postoperative lumen gain on the reduction of restenosis risk after endovascular treatment using drug-coated balloon for femoropopliteal lesions assessed by intravascular ultrasound. <i>J Atheroscler Thromb<\/i> 2023; 30: 1142\u20131151.","DOI":"10.5551\/jat.63886"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/5\/89_CJ-24-0813\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T03:14:32Z","timestamp":1745637272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/5\/89_CJ-24-0813\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0813","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"CJ-24-0813"}}